High density of CD66b in primary high-grade ovarian cancer independently predicts response to chemotherapy.
Alberto PosabellaPhilipp KöhnAlexandros LalosAlexander WilhelmRobert MecheraSavas SoysalSimone MuenstUwe GüthSylvia StadlmannLuigi TerraccianoRaoul Andre DroeserJasmin ZeindlerGad SingerPublished in: Journal of cancer research and clinical oncology (2019)
High CD66b neutrophil density in primary high-grade OC predicts good response to initial chemotherapy and longer recurrence-free survival independent of known risk factors.